Literature DB >> 29339295

Characteristics of clinical and environmental vanM-carrying vancomycin-resistant enterococci isolates from an infected patient.

Gensheng Zhang1, Xiuhui Lin2, Jiachang Cai3, Rong Zhang3, Huiqing Xiu1, Baoping Tian1, Wei Cui4.   

Abstract

vanM, an uncommon glycopeptide resistance gene, was first identified in an Enterococcus faecium isolate (Efm-HS0661) from Shanghai, China, in 2006 and has been predominant in this city since 2011. A vanM-carrying E. faecium was isolated from the bloodstream of a patient in an intensive care unit (ICU) in Hangzhou, China, in 2014. Further surveillance screening of a rectal swab and environmental surfaces of the patient yielded a large number of vanM-positive E. faecium. These isolates (including 1 from the bloodstream, 1 from the rectal swab and 43 representative isolates from environmental samples) were classified into four pulsed-field gel electrophoresis (PFGE) patterns and two sequence types (ST78 and ST564). PCR amplification and sequence analysis indicated that the genetic structure surrounding the vanM gene of these isolates was similar to that of the original vanM-carrying isolate Efm-HS0661. This study highlights the emergence of infections and environmental contamination caused by vanM-carrying E. faecium in an ICU of another Chinese city outside of Shanghai.
Copyright © 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Enterococcus faecium; Genetic context; Glycopeptide resistance; vanM gene

Mesh:

Substances:

Year:  2018        PMID: 29339295     DOI: 10.1016/j.ijantimicag.2018.01.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  1 in total

1.  Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017.

Authors:  Lin Huang; Rong Zhang; Yanyan Hu; Hongwei Zhou; Junmin Cao; Huoyang Lv; Shi Chen; Shibiao Ding; Gongxiang Chen
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-30       Impact factor: 4.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.